Equities

Haleon PLC

HLN:LSE

Haleon PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)396.60
  • Today's Change6.50 / 1.67%
  • Shares traded35.31m
  • 1 Year change19.66%
  • Beta--
Data delayed at least 20 minutes, as of Sep 27 2024 17:01 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,044606347
Total Receivables, Net1,8401,8713,825
Total Inventory1,4081,348951
Prepaid expenses10710656
Other current assets, total41912872
Total current assets4,8184,0595,251
Property, plant & equipment, net1,9021,8991,662
Goodwill, net8,3178,3968,246
Intangibles, net18,53820,04018,949
Long term investments------
Note receivable - long term114----
Other long term assets6517620
Total assets34,05534,81534,451
LIABILITIES
Accounts payable1,8551,8351,369
Accrued expenses1,2761,7631,412
Notes payable/short-term debt60393874
Current portion long-term debt/capital leases5964430
Other current liabilities, total853335553
Total current liabilities4,6404,3704,238
Total long term debt8,80010,00387
Total debt9,45610,440991
Deferred income tax3,4873,6013,357
Minority interest123126125
Other liabilities, total399384289
Total liabilities17,44918,4848,096
SHAREHOLDERS EQUITY
Common stock92921.00
Additional paid-in capital--00
Retained earnings (accumulated deficit)15,74915,19326,354
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total7651,046--
Total equity16,60616,33126,355
Total liabilities & shareholders' equity34,05534,81534,451
Total common shares outstanding9,2359,2359,235
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.